Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Dividend and Company Update

13 Nov 2023 12:52

RNS Number : 2674T
Jarvis Securities plc
13 November 2023
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Jarvis Securities plc

 

("Jarvis" or "the Company")

 

DIVIDEND UPDATE

COMPANY UPDATE

 

 

Dividend Update

In line with current market expectations, the Company confirms that it is not declaring a fourth quarter dividend (total interim dividend for the twelve months ended 31 December 2023: 8.75p).

 

Company Update

The Company also provides a further update on the skilled person review announced on 16 September 2022 (the "Announcement"). The Company advises that pursuant to section 166 of the Financial Services and Markets Act 2000 ("s.166") ("FSMA"), an additional review (known as phase 1c) ("Phase 1c") is required by the FCA to be undertaken in respect of its subsidiary, Jarvis Investment Management Ltd ("JIML") . Phase 1c will review JIML's approach to uninvested client cash, interest retention and term deposits. The voluntarily agreed restrictions on new Model B business and assets, as detailed in the Announcement, remain in place.

 

The Phase 1C report is due to be delivered to the FCA, by no later than 28 February 2024. Further updates will be provided as appropriate.

The FCA have also provided additional direction for the pre-existing Phase 2, if required. This phase would include a review and assurance report on the remediation work undertaken by JIML on the matters raised in any of the s.166 reports. This review may be required before the voluntary restrictions on JIML's new business and assets can be lifted. As previously announced, whilst these restrictions remain in place dividends payable by JIML to the Company, and therefore dividends payable by the Company, may be reduced and or delayed.

 

Finally, the Directors confirm that the costs associated with the s.166 process, including reports and remediation work, are expected to exceed £1.3m in the current financial year (for the twelve months ended 30 December 2023) (unaudited). Further updates will be provided, as appropriate.

 

Despite these challenges, Jarvis continues to trade in line with current market expectation.

 

Enquiries:

 

Jarvis Securities plc 01892 510 515

 

Andrew Grant

 

WH Ireland Limited 0207 220 1666

 

Katy Mitchell / Darshan Patel

 

Notes:

 

Jarvis Securities plc is the holding company for Jarvis Investment Management Limited (AIM: JIM.L) a stock broking company and outsourced service provider for bespoke tailored financial administration. Jarvis was established in 1984 and is a member of the London Stock Exchange; a broker dealer member of Aquis Stock Exchange, authorised and regulated by the Financial Conduct Authority and an HM Revenue & Customs approved ISA manager. As well as normal retail broking Jarvis provides cost effective and flexible share trading facilities within ISA and SIPP wrappers.

 

Jarvis provides outsourced and partnered financial administration services to a number of third party organisations. These organisations include advisers, stockbrokers, banks and fund managers. Jarvis can tailor its administration processes to the requirements of each organisation and has a strong reputation for flexibility and cost-effectiveness.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFEFLILVLIV
Date   Source Headline
29th May 20262:10 pmRNSResult of GM
12th May 202611:55 amRNSNotice of GM
8th May 202611:57 amRNSConditional Property Sale, RPT & Proposed GM
5th May 20267:00 amRNSUpdate on JIML
30th Mar 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSResult of GM
27th Jan 20267:00 amRNSNon-Executive Director Appointment
15th Jan 20262:52 pmRNSHolding(s) in Company
30th Dec 20257:00 amRNSAudited Results, FCA Update & Notice of GM
30th Dec 20257:00 amRNSAudited Results, FCA Update & Notice of GM
23rd Dec 202511:47 amRNSHolding(s) in Company
23rd Dec 202511:47 amRNSHolding(s) in Company
23rd Dec 202511:25 amRNSHolding(s) in Company
23rd Dec 202511:25 amRNSHolding(s) in Company
23rd Dec 202511:09 amRNSBoard Change
23rd Dec 202511:09 amRNSBoard Change
19th Dec 20254:14 pmRNSHolding(s) in Company
19th Dec 20254:14 pmRNSHolding(s) in Company
19th Dec 20254:07 pmRNSResult of AGM
19th Dec 20254:07 pmRNSResult of AGM
11th Dec 20258:20 amRNSNotice of AGM
30th Sep 202510:20 amRNSAccounts Timetable Update
31st Jul 20254:30 pmRNSDividend Declaration and Company Update
7th Jul 20259:18 amRNSSale of Retail Execution-only Brokerage Business
27th Jun 20257:05 amRNSSecond Interim Results
27th Jun 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:00 pmRNSSale of Retail Brokerage & Strategic Direction
20th Feb 20257:00 amRNSDividend Declaration
14th Nov 20247:00 amRNSDividend Declaration
25th Oct 202410:25 amRNSHolding(s) in Company
25th Oct 202410:24 amRNSHolding(s) in Company
25th Oct 202410:22 amRNSHolding(s) in Company
25th Oct 202410:19 amRNSHolding(s) in Company
23rd Oct 202412:41 pmRNSDirector / PMDR Shareholding
30th Aug 20245:08 pmRNSTR - 1
30th Aug 202412:02 pmRNSTR - 1
30th Aug 202412:00 pmRNSTR - 1
30th Aug 202412:00 pmRNSTR - 1
8th Aug 20247:01 amRNSDividend Declaration
8th Aug 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
27th Jun 20247:25 amRNSUpdate
9th May 20247:00 amRNSDIVIDEND DECLARATION
18th Apr 20244:20 pmRNSANNUAL GENERAL MEETING
18th Apr 20244:11 pmRNSProxy Votes
17th Apr 20244:15 pmRNSStrategic Update
26th Mar 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
15th Feb 20247:00 amRNSDividend Declaration
13th Nov 202312:52 pmRNSDividend and Company Update
31st Oct 20232:35 pmRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.